Abstract
Plasma samples from patients undergoing treatment in malaria endemic countries often contain anti-malaria drugs, that may overstate effects of specific antibodies in growth inhibition assays (GIA). We describe a modified assay that uses drug resistant P. falciparum parasites (W2) that circumvents the requirement for dialyzing samples that may likely contain drugs such as chloroquine and sulfadoxine/pyrimethamine (SP).
Original language | English (US) |
---|---|
Pages (from-to) | 211-214 |
Number of pages | 4 |
Journal | Experimental Parasitology |
Volume | 115 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2007 |
Keywords
- Growth inhibition assay
- Plasmodium falciparum
ASJC Scopus subject areas
- Parasitology
- Immunology
- Infectious Diseases